From: Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study
 | Percentage of weight change | ||||
---|---|---|---|---|---|
Metabolic syndrome components | Loss group (<-2.5%) | Stable group (-2.5 to 1.2%) | Mild gain group (1.3 to 3.9%) | Moderate gain group (4 to 7.6%) | Large gain group (≥ 7.7%) |
High WC | 0.3 (0.2–0.7) | Reference | 1.9 (1.1–3.2) | 2.8 (1.6–5.0) | 7.3 (4.1–13.0) |
No. of subjects †| 149 | 162 | 206 | 192 | 286 |
P value | .003 | Â | .03 | < 0.001 | < 0.001 |
High TG | 0.7 (0.4–1.2) | Reference | 1.2 (0.7–2.1) | 2.1 (1.3–3.6) | 2.7 (1.7–4.4) |
No. of subjects †| 173 | 201 | 202 | 204 | 294 |
P value | 0.2 | Â | 0.5 | 0.003 | < 0.001 |
Low HDL-C | 0.7 (0.4–1.2) | Reference | 0.9 (0.5–1.6) | 1.1 (0.6–2.0) | 1.5 (0.8–2.7) |
No. of subjects †| 101 | 107 | 96 | 99 | 119 |
P value | 0.2 | Â | 0.7 | 0.7 | 0.2 |
High FPG | 0.7 (0.3–1.6) | Reference | 1.6 (0.8–3.1) | 1.5 (0.7–2.9) | 4.3 (2.2–8.2) |
No. of subjects †| 307 | 339 | 340 | 358 | 396 |
P value | 0.4 | Â | 0.1 | 0.3 | < 0.001 |
High BP | 0.9 (0.5–1.8) | Reference | 2 (1.1–3.5) | 1.3 (0.7–2.5) | 2.1 (1.1–3.7) |
No. of subjects †| 244 | 240 | 256 | 263 | 338 |
P value | 0.9 | Â | 0.02 | 0.3 | 0.01 |